Home Cart 0 Sign in  

[ CAS No. 5468-66-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5468-66-6
Chemical Structure| 5468-66-6
Structure of 5468-66-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5468-66-6 ]

Related Doc. of [ 5468-66-6 ]

Alternatived Products of [ 5468-66-6 ]

Product Details of [ 5468-66-6 ]

CAS No. :5468-66-6 MDL No. :MFCD02093922
Formula : C14H11ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :COGUOPIIFAMLES-UHFFFAOYSA-N
M.W : 242.70 Pubchem ID :225500
Synonyms :

Calculated chemistry of [ 5468-66-6 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.07
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 70.56
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -4.83 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.15
Log Po/w (XLOGP3) : 4.16
Log Po/w (WLOGP) : 3.81
Log Po/w (MLOGP) : 3.33
Log Po/w (SILICOS-IT) : 4.53
Consensus Log Po/w : 3.6

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.49
Solubility : 0.00792 mg/ml ; 0.0000326 mol/l
Class : Moderately soluble
Log S (Ali) : -4.47
Solubility : 0.00822 mg/ml ; 0.0000339 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.46
Solubility : 0.0000851 mg/ml ; 0.000000351 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.76

Safety of [ 5468-66-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5468-66-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5468-66-6 ]
  • Downstream synthetic route of [ 5468-66-6 ]

[ 5468-66-6 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 1878-66-6 ]
  • [ 95-54-5 ]
  • [ 5468-66-6 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: at 110℃;
Stage #2: at 120℃; for 1 h;
(101.8 mmol) of 4-chlorophenylacetic acid and 0.37 mg (0.46 mmol) of sodium benzoate were added to a 50 ml reaction flask equipped with a mechanical stirrer, thermometer, water separator and reflux condenser. The temperature was increased to 110 C, and 10 g (92.5 mmol) of o-phenylenediamine was added thereto, and the temperature was raised to 120 ° C for 1 hour. The reaction process and reaction endpoint were monitored by TLC (Developing solvent: ethyl acetate: petroleum ether = 1: 1, Rf = 0.41). The reactants were neutralized with 5 wtpercent Na0H solution and stirred until the pH was 7. 0 to 8.5; filter, washed with water to neutral crude, with ethanol - water mixed solvent recrystallization (volume ratio of 1: 2 ~ 1: 3), filtration, drying in pure 21 3g, the
85% With boric acid In 5,5-dimethyl-1,3-cyclohexadiene for 16 h; Reflux General procedure: To a stirred solution of benzene-1,2-diamine 1 (1.85 mmol)in xylenes (10 mL) were added carboxylic acid 2 (2.77 mmol)and boric acid (0.185 mmol). The resulting solution wasrefluxed for 16 h. After cooling to room temperature, the reactionwas concentrated under reduced pressure and diluted withEtOAc (50 mL). The organic phase was washed with saturatedNaHCO3 solution (2 50 mL), dried over anhydrous Na2SO4and then concentrated under reduced pressure. The residuewas purified by silica gel flash column chromatography (elutingwith 10–15percent Ethyl acetate in hexanes) to afford the title compounds3a–y and 5.6.2.5
2-(4-Chlorobenzyl)-1H-benzo[d]imidazole (3e)
Yield 85percent; Off white solid; mp 191-194 °C; IR (KBr) 2850, 2751, 1512, 1451, 1410, 1241, 1181, 1025, 812, 749 cm-1; 1H NMR (400 MHz, DMSO-d6) δ 12.26 (br s, 1H), 7.52 (br s, 1H), 7.31-7.45 (m, 5H), 7.07-7.16 (m, 2H), 4.17 (s, 2H); 13C NMR (100 MHz, DMSO-d6) δ 153.2, 136.7, 134.5, 131.3, 130.8, 128.5, 121.8, 121.1, 118.3, 111.0, 34.1; HRMS calcd for C14H11ClN2 m/z 242.0625, found 242.0621.
Reference: [1] Patent: CN103483266, 2016, B, . Location in patent: Paragraph 0054; 0055; 0056
[2] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 8, p. 1872 - 1878
[3] Journal of the American Chemical Society, 1954, vol. 76, p. 1883,1886
[4] Pharmazie, 2003, vol. 58, # 5, p. 303 - 307
  • 2
  • [ 43002-66-0 ]
  • [ 95-54-5 ]
  • [ 5468-66-6 ]
YieldReaction ConditionsOperation in experiment
89% at 20℃; General procedure: To a well stirred solutionof o-phenylenediamine (0.01 mol) in methanol (30 mL),compounds 1a, b (0.012 mol) was added and stirred at roomtemperature overnight. After the reaction was completed(monitored by TLC, ethyl acetate:hexane, 3:1), the productwas precipitated by addition of water and it was filtrated,dried and recrystallized from ethanol-water (1:1).
Reference: [1] Letters in Organic Chemistry, 2015, vol. 12, # 4, p. 227 - 232
  • 3
  • [ 873-73-4 ]
  • [ 95-54-5 ]
  • [ 5468-66-6 ]
Reference: [1] Synlett, 2009, # 12, p. 2023 - 2027
  • 4
  • [ 1875-88-3 ]
  • [ 95-54-5 ]
  • [ 5468-66-6 ]
Reference: [1] Catalysis Science and Technology, 2016, vol. 6, # 6, p. 1677 - 1684
Same Skeleton Products
Historical Records